• Box
    Body

    Abilify Maintena PBS Information: Authority required (STREAMLINED). Code: 4246 for schizophrenia.
    This product is not listed on the PBS for the treatment of bipolar 1 disorder.

  • Box
    Body

    Brintellix PBS information: This product is not listed on the PBS.

  • Box
    Body

    REXULTI PBS Information: Authority required (STREAMLINED). Code: 4246 for schizophrenia

  • Box
    Body

    Vyepti PBS Information: This product is not listed on the PBS.

  • Box
    Body

    Lexapro PBS Information: Restricted benefit.
    Major Depressive Disorders, moderate to severe Generalised Anxiety Disorder, and moderate to severe Social Anxiety Disorder. Refer to PBS Schedule for full information.

  • Footer text
    Body

    Please review Approved Product Information before prescribing.
    Product Information is available by calling Lundbeck on 1300 721 277 or by clicking:

    Abilify Maintena PI Brintellix PI REXULTI PI Vyepti PI Lexapro PI

    References: 1. Abilify Maintena Australian Product Information. 2. Brintellix Australian Product Information. 3. REXULTI Australian Product Information. 4. Vyepti Australian Product Information. 5. Lexapro Australian Product Information

    Abilify Maintena is a registered trademark of Otsuka Pharmaceutical Co., Ltd. Brintellix, REXULTI,Vyepti and Lexapro are registered trademarks of H. Lundbeck A/S. Abilify Maintena® and REXULTI® are co-commercialised by Lundbeck Australia and Otsuka Australia Pharmaceutical Pty Limited.